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1. Introduction
For  most  patients  with  end-stage  heart  failure  (more  than  90%)  there  is  no  definitive
treatment option up to now. This fact is caused on the one hand by a severe shortage in
donor hearts, and on the other hand by technical and economic limitations of mechanical
cardiac assist  devices and artificial  hearts.  An additional cardiac output of  2-3 litres per
minute should give most patients with end-stage heart failure a better quality of life and
a longer survival. Latissimus dorsi muscle as a source for muscular blood pumps would
have  several  advantages.  Its  availability  is  nearly  unlimited,  there  is  no  foreign  tissue
rejection and of course no need for an immune-suppression, less risk of infection and this
procedure should be less  costly  than heart  transplantation and the treatment  with fully
implantable cardiac assist devices and artificial hearts.
Skeletal muscle ventricles (SMVs) and Biomechanical Hearts (BMHs) are experimental
muscular blood pumps to support the circulation. They are developed and tested as future
treatment option for patients with end stage heart failure. SMVs and BMHs basically have two
main limitations: firstly muscle damage after electrical muscle fiber transformation from a fast
twitched into a slow twitched non-fatigue muscle and secondly thromboembolic complica‐
tions from the blood contacting surface especially when a muscular blood pump works on
demand. Former investigators developed sack-ventricles within circulation in dogs pumping
up to 4 years [1-5].
© 2013 Guldner et al.; licensee InTech. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Figure 2. Topography of the latissimus dorsi muscle (LDM) in a big animal (goat) and a human. LDM consists of three parts:
Pars transversalis (1), Pars obliqua (2) and Pars lateralis (3), LDMs weight is 300 to 450g in Boer bocks and about 600g in hu‐
mans.
Figure 1. Boer goats with a weight between 60 and 100 kg and a latissimus dorsi muscle of 300 to 450 g.
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2. Training device
To study muscle protection of LDM under different stimulation patterns and drugs to improve
muscular power an elastic training device was created, where the LDM was wrapped around
and muscle performance could become evaluated [6].
The training device (Figure 3) is made of silicone rubber (Q3, Dow Corning). It consists of a
central chamber and two compliant side bladders filled with saline solution. The barrel-shaped
central chamber and the side bladders have volumes of 150 mL and 50 mL each, respectively.
The side bladders are constructed with a compliance of 1.0 to 1.3 mL/mmHg, simulating the
windkessel characteristics of the arterial system in normal subjects with 1.07 mL/mmHg. More
technical details can be found elsewhere (Guldner et al.,1994; 2000).
Figure 3. The Frog, an elastic training device, made of silicone, consists of a central pumping chamber which is com‐
pressible but not extendible (carbon fibre mesh).
3. Intra-thoracic implantation
Experiments were carried out in adult Boer goats (Figure 1), with a weight of 70±11 kg. They
were castrated 4 weeks before the operation to keep them together and avoid injuries between
them. The experiments were performed in accordance with the Guide for the Care and Use of
Laboratory Animals published by the National Institutes of Health. They were supervised by
a representative of the District President of the local society for Prevention of Cruelty to
Animals.
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The operation was performed under general anaesthesia. Left LDM was dissected free, folded
to a double layer, and wrapped around the central chamber of the training device. The SMV
was transferred into the thorax and fixed at the thoracic wall.
Commercially available myostimulators were used (Medtronic model 7420/7424 and Tele‐
ctronics model 7220). An epi-mysial electrode 30mm long (custom-made, Medtronics, Bakken
Research Center) was attached to the muscle close to the branches of the nervus thoracodor‐
salis. On the opposite side of the muscle, an electrode 60mm long (Medtronics SP 5591 – 500-60-
NMS) was placed sub-fascially.
Figure 4. An intra-thoracic skeletal muscle ventricle is wrapped around the Frog: A myostimulator induces muscle
contractions via 2 electrodes. Contractions of LDM cause a volume shift from the central chamber into the expanding
bladders, with a corresponding pressure increase. This pressure is measured by piercing a subcutaneous vascular ac‐
cess port (PaC).
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Figure 5. Method of stroke volume and stroke energy determination, relating pressure increase of a ventricle contrac‐
tion (left) to the compliance curve of the bladders of the Frog, stroke volume is received (right). The area of the stroke
volume below the compliance curve represents the stroke work or stroke energy [7].
Stroke volume evaluation is performed relating maximal pressure Pmax from the pressure curve
during muscle contraction to the compliance curve of the Frog’s elastic side bladders (Figure
5). Stroke volume multiplied with Pmax results in stroke work W. Daily energy in KJ/d is to
calculate by stroke work W multiplied with the number of SMV contractions per day.
4. Clenbuterol supported dynamic training of skeletal muscle ventricles
against systemic load
The profound loss of power that occurs in skeletal muscle after electrical conditioning has been
the major limiting factor in its clinical application. This study investigates a 3-fold approach
for chronic conditioning of skeletal muscle ventricles combining electrical transformation,
dynamic training against systemic load and pharmacological support with clenbuterol.
In 10 adult male goats, SMVs were constructed from latissimus dorsi wrapped around an
intrathoracic training device with windkessel characteristics [8]. SMVs were stimulated
electrically and trained dynamically by shifting volume against systemic load. Group 1 goats
were controls (n=5), and group 2 goats (n=5) were supported with clenbuterol (150µg 3 times
a week).
Peak pressure, stroke volume and stroke work per day were significantly improved (p< 0.007)
in the clebuterol- treated group after 151±2.7 days (Fig. 6). At termination, myosin heavy chains
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were totally transformed into myosin heavy chain-I in all SMVs. Other investigators found
different functional and histological effects of clenbuterol in dogs [9].
Figure 6. Time course of systolic pressure (top), stroke volume (middle), and power per day ( bottom) during dynamic
training of SMVs without Clenbuterol n=5 (left) and supported by clenbuterol n=5 (right) against load conditions of 60 to
70 mm Hg [8].
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Figure 7. Cross-section areas of clenbuterol treated (β-2-stimulated) muscle fibers were enhanced by 59%.
5. Fibertransformation preserving non-fatiguable Typ IIa fibers
In our experience muscular blood pumps that were active over several months, were highly
vulnerable when totally transformed into type I muscle showing severe muscle damage and
decreased function. Thus, in our new experimental setting, encouraged by the Liverpool
findings of the working group of Salmons and Jarvis [10], fast and fatigue resistant muscle
ventricles were performed around the Frog. Pre-stimulation with about 2 Hz proceeded in
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situ, to open intramuscular collaterals connecting the proximal with the distal blood supply
of the muscle and to increase capillary density. Thereafter we used continuous basic burst
stimulation with an average pulses frequency of less than 1 Hz. Intermittent series of pumping
within the Frog were performed, measuring pumping capacity in correlation to stimulation
frequency. This procedure should be a “model setting” for a pumping on demand. During our
first investigations, we could see that intermittent pumping capacity was already manifold
after 4 to 5 months of pumping (Figure 8).
Figure 8. Daily energy of goat A (lower curve) with a mean pulse frequency of 5 Hz, which is massively declined. With
1 Hz stimulation in goat B however (upper curve) a high pumping capacity was observed.
Mean electrical pulse frequency with 5 Hz of group A (n=6) in Fig.9 resulted in a non relevant
delivery of daily energy after 200 days of pumping. A 1 Hz stimulation of group B however
showed an enhancing pressure and stroke volume and an increasing development of daily
energy after 200 days with a well preserved muscular tissue.
Gel electrophoresis for myosin heavy chains MHC I and MHC IIa analysis (Figure 10) of group
A with a mean pulse frequency of 5Hz showed a composition of MHC I (bottom of the gel)
and MHC IIa (top of the gel) with mainly MHC IIa in the controls (C). In the trained SMVs (T)
of group A was 100% MHC-I in all cases. In group B and with 1 Hz stimulation over months
MHCIIa was preserved (50% MHC-IIa and 50% MHC-I). The preservation of Type II MHC in
group B explains the more powerful contractions and the maintained pressure, stroke volume
and daily energy (Figure 9).
Regenerative Medicine and Tissue Engineering348
015
30
45
60
75
90
105
0 50 100 150 200 250
days
Andy Warhol
Gerhard
Greta
Hanna
Harrison
Tapier
Mittelwert
Stroke volume [ml]
0
50
100
150
200
250
300
350
0 50 100 150 200 250
days
Andy Warhol
Gerhard
Greta
Hanna
Harrison
Tapier
Mittelwert
Pressure [mmHg]
0
50
100
150
200
250
300
350
0 50 100 150 200 250
days
[mmHg]
Clen
Horst Jannsen
Ingo
Jens
Leo (C6)
Norbert
Mittelwert
0
15
30
45
60
75
90
105
0 50 100 150 200 250
days
[ml] Clen
Horst Jannsen
Ingo
Jens
Leo (C6)
Norbert
Mittelwert
Functional analysis of SMVs over more than 6 months of electrical stimulation
Group A: 5 Hz n=6 Group B: 1 Hz n=6
 Daily Energy [kJ/d]
0
5
10
15
20
25
30
35
0 50 100 150 200 250
days
Andy Warhol
Gerhard
Greta
Hanna
Harrison
Tapier
Mittelwert
[kJ/d]
0
5
10
15
20
25
30
35
0 50 100 150 200 250
days
Clen
Horst Jannsen
Ingo
Jens
Leo (C6)
Norbert
Mittelwert
Figure 9. Systolic pressure (top),stroke volume (middle) and daily energy (bottom) of group A (n=6) with a mean pulse
frequency of 5 Hz (left) and with 1 Hz in group B (n=6, right).
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Figure 10. Gel electrophoresis of myosin heavy chains MHC I and MHC IIa from group A with a mean pulse frequency
of 5 Hz. Control (C) was the non stimulated contra-lateral LDM. In group B with a mean stimulation frequency of 1 Hz,
type IIa MHC is well preserved and about 50% after several months in all stimulated SMVs.
6. Stroke volume of SMVs with 100% type-I-fiber (A) vs. SMVs with 50%
type-IIa fiber (B)
As an example one fast, relatively fatigue resistant SMV delivered a maximal pump volume of
about 3 L/min. It could be maintained over two minutes. Thereafter it decreased to 1,5 L/min
after 5 minutes. This dynamic adaptation of stroke volume per minute in that high level of
pumping volume up to 3 L/min was solely possible in the 50% type IIa fibre muscle. 100 % type
I fibre ventricles did enhance its pumping capacity however only up to 1 L/min.
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Figure 11. Stroke volumes evaluated in a Frog surrounded by a goat’s SMV of a latissimus dorsi muscle of 330g up to
200 days postoperatively. In group A with 100% type I fibres stroke volume per minute was at 405 ml and in the fast,
relatively fatigue resistant muscle with about 50% type IIa fibres stroke volume per minute was at 888 ml per minute.
This amount of stroke volume per minute could be maintained over months.
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Figure 12. Stroke volumes of an “on demand” setting (see text!) evaluated in a Frog surrounded by a goat’s SMV of a
latissimus dorsi muscle of 330g 6 weeks postoperatively.
These recent experimental results in SMVs around the Frog were basic to construct a pre-
clinical Biomechanical Heart Model on demand, which is described as follows.
7. Valve-less Biomechanical Hearts
Biomechanical Hearts, constructed in adult Boer goats (n=5), are blood pumps, consisting of a
pumping chamber with clinically relevant stroke volumes [11]. They can be integrated into the
circulation in a one-step operative procedure during pharmacological stimulation with the
β-2-stimulator Clenbuterol (5 x150µg/wk). This experimental pumping chamber, made of
PTFE, was anastomosed to the descending aorta by two ring armoured PTFE-prostheses
(Impra Medica GmbH, München), as shown in Figure 13. The pumping chamber was used
mainly for three reasons: firstly, to stabilize the ventricular pump cavity with improved flow
characteristics to minimize thrombo-embolic complications; secondly, to prevent muscle
damage by overstretch-induced ischemia; and thirdly, to prevent a ventricular chamber
rupture.
During  surgery,  the  mean  stroke  volume  of  BMHs was  53.8±22.4  ml.  One  month  after
surgery, in peripheral pressure, the mean and minimal diastolic pressure of BMH-support‐
ed  heart  cycle  differed  significantly  from  unsupported  ones  (Figure  14).  After  BMH-
supported heart contractions, the subsequent maximal rate of pressure generation, dP/dt
max increased by 20.5±8.1% (p<0.02). One BMH, catheterized 132 days after surgery, shifted
a volume of 34.8 mL per beat and 1.4 L/min with a latissimus dorsi muscle of 330 g (Figure
14, top).
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Figure 14. Stroke volume determination with a conductance catheter, placed within the pumping chamber of the
BMH (left, top). Pressure-volume-loop of a BMH on postoperative day 132 with a stroke volume of 34.8 ml and an
output of 1400ml per minute (right, top). ECG with stimulation bursts, a pressure trace from a peripheral artery where
the BMH is in a 1:2 mode and synchronized with the heart (bottom).
Figure 13. Scheme of an experimental setting in a big animal model in an aorto-aortic configuration. The thoracic
aorta is ligated between the two anastomoses. Two muscular stimulation electrodes activate the LDM and an epicar‐
dial sensing electrode enables the syncronization with the heart cycle.
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Figure 15. Explanted BMH without valves after 414 days of pumping within a Boer goat. The pumping chamber was
made of a double layered polyurethane membrane including steel springs and it was connected to the aorta by ring
armoured PTFE prostheses.
8. Hemodynamic evaluations of a valve equipped Biomechanic Heart
Model supporting a failing myocardium in goats
As shown previously in goats, valve-less Biomechanical Hearts (BMHs) of a clinically relevant
size could be trained effectively in the systemic circulation under support of clenbuterol.
Pumping capacity was more than 1 L/min but due to a high pendulum volume no significant
flow contribution for the circulation was gained. Thus, the following investigations were
performed to evaluate the efficacy of valve-equipped BMHs in comparison to valve-less BMHs.
To mimic the clinical situation, this test was performed in failing hearts [12].
Heart failure was induced in adult Boer goats (n=5) by a repeated intra-coronary embolization.
A valve-bearing and balloon-equipped pumping chamber was integrated into the descending
aorta simulating standardized circulatory BMH support. Circulatory flow was evaluated by a
flow meter around the pulmonary artery. Myocardial function was evaluated by a conductance
catheter placed in the left heart ventricle (Figure 16).
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Figure 16. BMH model is made of a stiff polyurethane chamber with an integrated pumping balloon. The dividing and
re-uniting vascular prostheses were connected end –to-end with the divided descending aorta. In this setting two of
the four prosthetic limbs carried heart valves. Thus, by clamping, no, one or two valves could be integrated into the
circulation. The influence of different valve configurations on circulation could be evaluated in supporting a failing
heart. Ultrasonic flow probes were placed around the pulmonary artery, aortic arch and the descending aorta. Within
the left heart ventricle a conductance catheter was placed, and via a catheter within the left coronary artery an embo‐
lization could be induced and a flow wire could be introduced [12].
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Figure 17. Results of the BMH model described in Fig. 16, without, with a distal and with two valves: mean aortic pres‐
sure( PAo, grey column), mean pulmonary flow (QPA, black column), mean flow velocity within the left coronary artery
(VC, white column) [12].
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Valve-less BMHs offered an additional pulmonary flow of 113± 37 ml/min resp. 5.4±1.8%, those
with one distal valve offered 304±126 ml/min resp. 14.5±6%. BMHs equipped with two valves
increased the pulmonary blood flow by 1235± 526 ml/min resp. 58±25 % (p<0.05), the mean
aortic pressure in this setting raised to 19±9 mmHg (p<0.05) and the coronary flow velocity to
59±18 mm/sec (p<0.05). Corresponding reduction of left ventricle’s end-diastolic pressure
ranged from 31 to 17 mmHg (p<0.05), while the myocardial dp/dt increased by 470±192 mmHg/
s resp. 145±48 % (p<0.05).
Figure 18. PV- loops from a conductance catheter placed in the left heart ventriclea cavum, without (A) and with an
activated (B) double-valved BMH-model as shown in Figure16. It works ECG-triggered in a 1:2 mode with a balloon
inflation of 60ml helium gas. The area within a loop represents the left heart ventricles stroke work. During activation
of the BMH-model the stroke work of the failing heart ventricle is increased (B) and the end-diastolic pressure (LVEDP)
drops from 28 to 14 mmHg [12].
The use of two valves in BMHs is essential for a relevant circulatory support. Unloading and
contractility of the left heart ventricle were thus improved significantly. Two-valves-BMHs
driven by a sufficient skeletal muscle ventricle may contribute to the therapy of a failing
myocardium.
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Figure 19. Reduction of the left ventricular end-diastolic pressure (LVEDP, black columns) evaluated as demonstrated
in Figure 16 and 18 and an increase of the left ventricular contractility activation of the pumping balloon from the
BMH-model in Figure 16, without, with a distal and with a proximal and a distal valve.
9. Valve equipped Biomechanical Hearts
As demonstrated above, efficacy of BMHs on the circulation is dependent on the integration
of two heart valve prostheses into the in- and outflow part of the pumping chamber. Valve
equipped Biomechanical Hearts were constructed and integrated within circulation in adult
Boer goat (n=5), and pharmacological stimulation with the β-2-stimulator Clenbuterol.
(5X150µg/wk). This pumping chamber, made of PTFE, was anastomosed to the descending
aorta by two ring armoured PTFE-prostheses (Impra Medica GmbH, München). Between these
prostheses two porcine glutaraldehyde fixed valve bearing porcine aortic conduits were
integrated like shown in Figure 20.
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Figure 20. Scheme of an experimental setting from a valve equipped Biomechanical Heart in a big animal model (Boer
goats) in an aorto-aortic configuration. The thoracic aorta is ligated between the two anastomoses. Two porcine glu‐
taraldehyde fixed valve bearing porcine aortic conduits were integrated between the connecting PTFE prostheses and
the PTFE pump ventricle.
Figure 21. Operative situs of a BMH before transferring it into the cavity of the thorax, with four strings to fix it via the
thoracic wall to the inner thoracic surface. Two stimulation electrodes and an artificial muscle tendon made of Dacron
for a re-fixation onto the external thoracic wall are visible.
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Figure 22. Intraoperative testing of the function of a valve equipped BMH by visualization of burst stimulation within
the ECG, a 1:2 support within the arterial pressure curve and the flow curve which was obtained by a flow probe
around the distal biologic aortic conduit
Stroke
Volume (L/
min)
Type of
pumping
chamber
Days of
Pumping
Days of
Survival
MHC- I Significant Findings and Cause
of Death
Larry 1029,6 Dacron 93 93 56 % Seroma in both pleura
Juan 407,5 Dacron 267 301 95 % Acute abdomen, total thrombosis
of the pumping chamber,
sacrification
Ugo 444,5 Dacron 136 182 78 % Acute abdomen, total thrombosis
of the pumping chamber,
sacrification
Stanley 474,9 ePTFE
(titanized)
225 385 94 % Hematothorax, bleeding from
proximal conduit, no chamber
thrombus formation
Pierre 588 ePTFE
(titanized)
180 446 100 % Acute abdomen, intestinal
infection, no chamber thrombus
formation
Valeri 576,3 ePTFE
(titanized)
531 914 -- Infection, sepsis. no chamber
thrombus formation
Table 1. Intra- and post-operative data of six experimental valve equipped BMHs in adult Boer Goats
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10. Self-endothelializing titanized blood contacting surface for
Biomechanical Hearts
Titanium has proven itself as the leading structured metallic biomaterial for 50 years [13]. One
reason for this widespread use is the excellent biocompatibility of the metal and its alloys [14].
Theoretically, surface coating of the blood contacting PTFE may open new avenues for
improving biocompatibility of this kind of implant material. However, a titanium coating on
PTFE seemed not to be possible until now due to the high temperatures needed for commonly
used sputtering techniques. Therefore a novel coating method was used [15] for PTFE applying
a plasma activated chemical gas deposition (PACVD) at temperatures of 30-35°C.
Groups by plasma ernergy
Figure 23. Principle of titanium coating at low temperature (see text).
PACVD is a coating technology (Pfm Titanium GmbH, Nürnberg, Germany, patent number
EP 0 897 997 A1) where the so called precursor (Tetrakisdimethylamidotitanium, Ti
[N(CH3)2]4) is transferred into the gas phase and brought into the reactor by a carrier gas like
nitrogen gas [16]. The plasma is able to supply the substrate with high energy while the
temperature during deposition can be kept low at about 30-35°C. Within that non-thermal
plasma with high electron temperatures but neutrons and ions at room temperature, solely
the electrons can follow a quickly changing electrical field with a typical frequency of 13.56
MHz under low pressure plasma as described in detail elsewhere [17]. The precursor, or part
of it, reacts with the substrate and creates a layer of 30nm in thickness (Figure 23).
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The blood contacting surface of the PTFE-made pumping chamber was titanized as described
above. This titan surface attracts progenitor cells derived from the bone marrow which were
delivered into circulation. The seeded cells transform into endothelial cells within time [18].
This kind of self-tissue engineering of the blood contacting surface is mandatory to prevent
thrombo-embolism mainly for blood pumps contracting on demand [14].
 
Figure 24. Thrombosis of the total blood contacting surface 8 weeks after implantation (left): Isolated thrombus for‐
mation from the PTFE- pumping chamber (right).
 
Figure 25. Titanized PTFE pumping chamber 6.5 months after implantation without any thrombus formation. This
thin cover could be identified as an endothelial layer by a von Willebrand immun-histological staining.
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Figure 26. Clinical setting of a BMH in an aorto-aortic configuration
11. Summary and perspectives
A BMH is therapeutically indicated for patients with end-stage heart failure with an additional
need of a support with 2-3 litres per minute “on demand”, especially for candidates older than
60 years having no chance for heart transplantation. For a severe bi-ventricular myocardial
insufficiency however, heart transplantation is the first choice.
Experimental Biomechanical Hearts in Boer goats with autologous skeletal muscle were to
construct pumping up to 1.400 mL/min for more than 400 days under support of Clenbuterol.
Furthermore was to demonstrate that a BMH model supporting a failing heart in Boer goats
could pump about 2 litre blood per minute additionally. BMHs equipped with two valves were
most effective in-vivo. Effective circulatory support by counter pulsation was achieved by
SMVs elsewhere [19].
Muscle damage and power-loss of a BMH can be avoided by a muscle protective myostimu‐
lator applying a closed-loop controlled stimulation and thus maintaining type IIa fibres over
years (Microstim GmbH, MyoSen®, Wismar; Germany). A titanized blood contacting surface
with endothelialization (Pfm titanium GmbH, Nürnberg; Germany) might prevent thrombo-
embolic complications. In the light of 25 years of systematic progress in basic science of muscle
powered cardiac assist this biologic treatment option should become reconsidered as a future
surgical treatment option for the therapy of end-stage heart failure [20].
Regenerative Medicine and Tissue Engineering362
Acknowledgements
We thank Prof. Dr. Petra Margaritoff, Hamburg University of Applied Sciences, Germany for
critical reading of the manuscript.
Author details
Norbert W. Guldner1, Peter Klapproth2, Hangörg Zimmermann3 and Hans- H. Sievers1
*Address all correspondence to: Guldner@uni-luebeck.de
1 Clinic of Cardiac Surgery, University of Lübeck, Germany
2 Microstim GmbH, Wismar, Germany
3 Pfm Titan GmbH Nürnberg, Hangörg Zimmermann, Germany
References
[1] Acker MA, Hammond RL, Mannion JD, Salmons S, Stephenson LW. Skeletal muscle
as the potential power source for a cardiovascular pump: assessment in vivo Science
236 (1987), 324-327.
[2] Bridges Jr. CR, Brown WE, Hammond RL, Anderson DR, Anderson WA, DiMeo F,
Stephenson LW. Skeletal muscle ventricles: Improved performance at physiologic
preloads . Surgery 106 (1989), 275-28.
[3] Hooper TL, Niinami H, Hammond RL, Lu H, Ruggiero R, Pochettino A, Stephenson
LW. Skeletal muscle ventricles as left atrial-aortic pumps: short-term studies . Ann
Thorac Surg 1992;54:316-322.
[4] Lu H, Fietsam R, Jr., Hammond RL, Nakajima H, Mocek FW, Thomas GA, Ruggiero
R, Colson M, Stephenson LW. Skeletal muscle ventricles: left ventricular apex to aor‐
ta configuration . Ann Thorac Surg 1993;55:78-85.
[5] Thomas GA, Hammond RL, Greer K. Functional assessment of skeletal muscle ven‐
tricles after pumping for up to four years in circulation. Ann Thorac Surg 2000; 70 (4):
1281-1289.
[6] Guldner NW, Eichstaedt HC, Klapproth P, Tilmans MHJ, Thuaudet S, Umbrain V,
Ruck K, Wyffels E, Bruyland M, Sigmund M, Messmer BJ, Bardos P. Dynamic train‐
ing of skeletal muscle ventricles. A method to increase muscular power for cardiac
assistance. Circulation 89 (3):1032-1040 (1994).
Skeletal Muscle Ventricles (SMVs) and Biomechanical Hearts (BMHs) with a Self Endothelializing Titanized…
http://dx.doi.org/10.5772/55993
363
[7] Klapproth P, Guldner NW, Sievers HH. Stroke volume validation and energy evalu‐
ation for the dynamic training of skeletal muscle ventricles. Int.J Artif Organs 1997;
20:313-21.
[8] Guldner NW, Klapproth P, Großherr M, Rumpel E, Noel R, Sievers HH. Clenbuterol
supported Dynamic Training of Skeletal Muscle Ventricles Against Systemic Load- A
Key for Powerful Circulatory Assist ? Circulation 101:2213-2219 (2000)
[9] Sharif Z, Hammond RL, Mc Donald P, Vander Heide R, Stephenson LW. The func‐
tional and histological effects of clenbuterol on the canine skeletal muscle ventricle. J
Surg Res. 123, 89-95 (2005)
[10] Lopez-Guajardo A, Sutherland H, Jarvis JC, Salmons S. Induction of a fatigue-resist‐
ant phenotype in rabbit fast muscle by small daily amounts of stimulation. J Appl
Physiol. 2001; 90 (5):1909-18
[11] Guldner NW, Klapproth P, Großherr M., Rumpel E, Noel R, Sievers HH. Biomechan‐
ical Hearts: Muscular Blood Pumps, Performed in a One-Step Operation, and
Trained under Support of Clenbuterol, Circulation 2001;104 717-22.
[12] Guldner NW, Klapproth P, Margaritoff PRJ, Noel R, Sievers HH, Großherr M. The
Impact of Valves in a Biomechanical Heart Model Assisting Failing Hearts. Asian
Cardiovasc Thorac Ann 2009;17:1-6
[13] Sivaram S. Chemical vapor deposition: thermal and plasma deposition of electronic
materials.Van Nostrand Reinhold, New York. 1995.
[14] Dag B. (Ed.) Surface Characterization.Wiley-VCH, Weinheim. 1997.
[15] Guldner NW, Jasmund I, Zimmermann H, Heinlein M, Girndt B, Meier V, Flüß F,
Rohde D, Gebert A, Sievers HH. Detoxification and Endothelialization of Glutaralde‐
hyde-Fixed Bovine Pericardium With Titanium Coating; Circulation;
2009;119:1653-1660
[16] Brunette DM. Titanium in medicine. Springer, Berlin, Germany. 2001.
[17] Sedelnikov N, Cikirikicioglu M, Osorio-Da Cruz S, Khabiri E, Donmez Antal A, Tille
JC, Karaca S, Hess OM, Kalangos A, Walpoth B. Titanium coating improves neo-en‐
dothelialisation of ePTFE grafts. Thorac Cardiovasc Surg. 2006; 54 suppl 1: 83-115.
[18] Guldner NW, Jasmund I, Zimmermann H, Heinlein M, Girndt B, Großherr M, Klin‐
ger A,Sievers HH. The First Self-Endothelialized Titanium Coated Glutaraldehyde-
Fixed Heart Valve Prosthesis within Systemic Circulation.J Thorac Cardiovasc Surg
2009, 138: 248-25
[19] Ramnarine IR, Capoccia M, Ashley Z, Sutherland H, Salmons S, Jarvis JC. Counter‐
pulsation From the Skeletal Muscle Ventricle and the Intraaortic Ballon Pump in the
Normal and Failing Circulations. Circulation. 114 [suppl I]: 1-15 (2006)
[20] Salmons S. Cardiac assistance from skeletal muscle: a reappraisal. Europ J of Cardio
thoracic Surg 35, 204-213 (2009)
Regenerative Medicine and Tissue Engineering364
